Evidence map›Paper›PMID 39209910›Full record

ArticleScientific reports2024

Knowledge, attitudes, and practice of physicians and pharmacists regarding the prevention and treatment of cardiovascular toxicity associated with cancer treatment.

Congxin Li, Wei Yan, Meiling Gao, Zhihan Zhang, Ling Zhao, Jingtao Ma, Xuejing Li, Yuan Gao, Dongxia Zhang, Shan Gao

Abstract readMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Congxin Li *Department of Pharmacy, Hebei Medical University Third Hospital, Shijiazhuang, 050051, China. congxinli@hebmu.edu.cn.
Wei Yan *Department of Pharmacy, Hebei Medical University Third Hospital, Shijiazhuang, 050051, China.
Meiling GaoDepartment of Pharmacy, Hebei Medical University Third Hospital, Shijiazhuang, 050051, China.
Zhihan ZhangDepartment of Nutrition, The Fourth Hospital of Hebei Medical University, Shijiazhuang, 050010, China.
Ling ZhaoDepartment of Pharmacy, Hebei Medical University Third Hospital, Shijiazhuang, 050051, China.
Jingtao MaDepartment of Cardiovascular, The Fourth Hospital of Hebei Medical University, Shijiazhuang, 050010, China.
Xuejing LiDepartment of Pharmacy, Hebei Medical University Third Hospital, Shijiazhuang, 050051, China.
Yuan GaoDepartment of Pharmacy, Hebei Medical University Third Hospital, Shijiazhuang, 050051, China.
Dongxia ZhangDepartment of Hepatology Infection, Bethune International Peace Hospital, Shijiazhuang, 050051, China.
Shan GaoDepartment of Pharmacy, Hebei Medical University Third Hospital, Shijiazhuang, 050051, China.

Funding

Hospital Pharmacy Project of Hebei Pharmaceutical Association No. 2020-Hbsyxhms0017National Natural Science Foundation of China No. 82003878Natural Science Foundation of Hebei Province No. H2021206026Research Foundation of Education Bureau of Hebei Province No. BJ2021053
6 · The paper itself

Abstract

This study aimed to explore physicians' and pharmacists' knowledge, attitudes, and practice (KAP) regarding the prevention and treatment of cardiovascular toxicity associated with cancer treatment. A multicenter cross-sectional study included physicians and pharmacists between April 2023 and June 2023. The study included 918 participants (514 physicians and 404 pharmacists). The average scores of knowledge, attitudes, and practice were 11.6 ± 3.39, 24.7 ± 2.6, and 26.3 ± 6.8 points. Sufficient knowledge was significantly associated with age ≥ 41 years (odds ratio (OR) = 2.745, 95% confidence interval (CI) 1.086-6.941, P = 0.033), male (OR = 2.745, 95% CI 1.150-2.223, P = 0.005), bachelor's degree (OR = 0.084, 95% CI 0.013-0.533, P = 0.009), master's degree and above (OR = 0.096, 95% CI 0.015-0.609, P = 0.013), physician occupation (OR = 7.601, 95% CI 1.337-43.207, P = 0.022), pharmacy department (OR = 18.858, 95% CI 3.245-109.57, P = 0.001), oncology department (OR = 4.304, 95% CI 2.426-7.634, P < 0.001), cardiology department (OR = 3.001, 95% CI 1.387-6.492, P = 0.005), hospitals located in Eastern China (OR = 1.957, 95% CI 1.120-3.418, P = 0.018), and hospitals located in Western China (OR = 3.137, 95% CI 1.783-5.518, P < 0.001). Positive attitudes were significantly associated with a senior professional title (OR = 2.989, 95% CI 1.124-7.954, P = 0.028) and hospitals located in Eastern China (OR = 0.424, 95% CI 0.257-0.698, P = 0.001), Western China (OR = 0.231, 95% CI 0.136-0.394, P < 0.001), and Southern China (OR = 0.341, 95% CI 0.198-0.587, P < 0.001). Proactive practice was significantly associated with male (OR = 1.414, 95% CI 1.029-1.943, P = 0.033), senior professional title (OR = 3.838, 95% CI 1.176-12.524, P = 0.026), oncology department (OR = 3.827, 95% CI 2.336-6.272, P < 0.001), and cardiology department (OR = 2.428, 95% CI 1.263-4.669, P = 0.008). Both physicians and pharmacists had positive attitudes toward the prevention and treatment of cardiovascular toxicity associated with cancer treatment, while their knowledge and practice were not as proactive.

Indexed as

Health Knowledge, Attitudes, PracticeNeoplasmsPharmacistsPhysiciansAdultAntineoplastic AgentsAttitude of Health PersonnelCardiotoxicityCardiovascular DiseasesCross-Sectional StudiesFemaleHumansMaleMiddle AgedSurveys and QuestionnairesAntineoplastic AgentsAttitudesCancer treatmentCardiotoxicityCross-sectional studyHealthcare providersHealth knowledgePractice

Identifiers

PMID39209910
PMCPMC11362540

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.